Bluedoor Private Wealth LLC acquired a new stake in Colgate-Palmolive Company (NYSE:CL – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 13,193 shares of the company’s stock, valued at approximately $1,043,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. CBIZ Investment Advisory Services LLC grew its position in Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after buying an additional 150 shares during the last quarter. Triumph Capital Management grew its position in Colgate-Palmolive by 62.9% in the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock valued at $26,000 after buying an additional 127 shares during the last quarter. Jessup Wealth Management Inc purchased a new position in Colgate-Palmolive in the 4th quarter valued at $26,000. Maseco LLP purchased a new position in Colgate-Palmolive in the 4th quarter valued at $27,000. Finally, Motiv8 Investments LLC purchased a new position in Colgate-Palmolive in the 4th quarter valued at $27,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on CL shares. Rothschild & Co Redburn set a $100.00 target price on Colgate-Palmolive and gave the company a “buy” rating in a report on Tuesday, April 21st. The Goldman Sachs Group reissued a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. UBS Group raised their target price on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a report on Monday, May 4th. TD Cowen reissued a “hold” rating and issued a $85.00 target price on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Finally, Barclays raised their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, May 5th. Twelve investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.88.
Colgate-Palmolive Trading Up 1.3%
NYSE:CL opened at $90.59 on Tuesday. The company has a market capitalization of $72.49 billion, a PE ratio of 35.25, a price-to-earnings-growth ratio of 4.72 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The stock has a fifty day simple moving average of $86.96 and a 200-day simple moving average of $86.38.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The business’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 EPS. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive’s payout ratio is 82.49%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
